An instrument-based screening assay for DNA-targeted anticancer drugs using resonance light scattering

Combinatorial Chemistry and High Throughput Screening

Volumn 13, Issue 5, 2010, Pages 383-392

  Chen, Zhanguang ^a   Liu, Guoliang ^a   Chen, Maohuai ^a   Chen, Xi ^b   Wu, Mingyao ^a   Chen, Xingtong ^a  

^a SHANTOU UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Anthracycline; Anticancer drug; Apparent equilibrium constant; DNA targeted; Inhibitory concentration 50; Instrument based screening; Resonance light scattering

Indexed keywords

DAUNORUBICIN; DOXORUBICIN; MITOXANTRONE; PIRARUBICIN;

ACCURACY; ARTICLE; CANCER SCREENING; CELL SCREENING; CONTROLLED STUDY; DRUG SCREENING; ELECTROPHORESIS; EQUILIBRIUM CONSTANT; FLUORESCENCE SPECTROSCOPY; GENE TARGETING; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; INFORMATION PROCESSING; LIGHT SCATTERING; PRIORITY JOURNAL; REPRODUCIBILITY; RESONANCE LIGHT SCATTERING; ULTRAVIOLET SPECTROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL LINE, TUMOR; CELL PROLIFERATION; COMBINATORIAL CHEMISTRY TECHNIQUES; DNA; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, AGAR GEL; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; HYDROGEN-ION CONCENTRATION; LIGHT; OSMOLAR CONCENTRATION; PLASMIDS; SCATTERING, RADIATION; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET;

ANIMALIA;

EID: 77955723056     PISSN: 13862073     EISSN: None     Source Type: Journal    
DOI: 10.2174/138620710791292949     Document Type: Article

References (38)

1. Palchaudhuri, R.; Hergenrother, P. J. DNA as a target for anticancer compounds: methods to determine the mode of binding and the mechanism of action. Curr. Opin. Biotech., 2007, 18, 497-503.
2. Eglen, R. M.; Gilchrist, A.; Reisine, T. An overview of drug screening using primary and embryonic stem cells. Comb. Chem. High T. Scr., 2008, 11 (7), 566-572.
3. Takahara, P. M.; Frederick, C. A.; Lippard, S. J. Crystal structure of the anticancer drug cisplatin bound to duplex DNA. J. Am. Chem. Soc., 1996, 118, 12309-12321.
4. Nafisi, S.; Hashemi, M.; Rajabi, M.; Tajmir-Riahi, H. A. DNA adducts with antioxidant flavonoids: morin, apigenin, and naringin. DNA Cell Biol., 2008, 27, 433-442.
5. Aaron, J. J.; Trajkovska, S. Fluorescence studies of anti-cancer drugs-analytical and biomedical applications. Curr. Drug Targets, 2006, 7, 1067-1081.
6. Kashanian, S.; Askari, S.; Ahmadi, F.; Omidfar, K.; Ghobadi, S.; Tarighat, F. A. In vitro study of DNA interaction with clodinafoppropargyl herbicide. DNA Cell Biol., 2008, 27, 581-586.
7. Chio-Srichan, S.; Réfrégiers, M.; Jamme, F.; Kascakova, S.; Rouam, V.; Dumas, P. Photosensitizer effects on cancerous cells: A combined study using synchrotron infrared and fluorescence microscopies. BBA-Gen. Subjects, 2008, 1780, 854-860.
8. Chourpa, I.; Manfait, M. Specific molecular interactions of acridine drugs in complexes with topoisomerase II and DNA. SERS and resonance Raman study of m-AMSA in comparison with o-AMSA. J. Raman Spectrosc., 1995, 26, 813-819.
9. Pasternack, R. F.; Bustamante, C.; Collings, P. J.; Giannetto, A.; Gibbs, E. J. Porphyrin assemblies on DNA as studied by a resonance light-scattering technique. J. Am. Chem. Soc., 1993, 115, 5393-5399.
10. Pasternack, R. F.; Collings, P. J. Resonance light scattering: A new technique for studying chromophore aggregation. Science, 1995, 269, 935-939.
11. Ling, J.; Huang, C. Z.; Li, Y. F.; Long, Y. F.; Liao, Q. G. Recent developments of the resonance light scattering technique: technical evolution, new probes and applications. Appl. Spectrosc. Rev., 2007, 42, 177-201.
12. Lu, W.; Band, B. S. F.; Yu, Y.; Li, Q. G.; Shang, J. C.; Wang, C.; Fang, Y.; Tian, R.; Zhou, L. P.; Sun, L. L.; Tang, Y.; Jing, S. H.; Huang, W.; Zhang, J. P. Resonance light scattering and derived techniques in analytical chemistry: past, present, and future. Microchim. Acta, 2007, 158, 29-58.
13. Huang, C. Z.; Li, K. A.; Tong, S. Y. Determination of nucleic acids by a resonance light-scattering technique with α, β, γ, δ, -tetrakis4-(trimethylammoniumyl) phenylporphine. Anal. Chem., 1996, 68, 2259-2263.
14. Zhang, L.; Huang, C. Z.; Li, Y. F.; Xiao, S. J.; Xie, J. P. Label-free detection of sequence-specific DNA with multiwalled carbon nanotubes and their light scattering signals. J. Phys. Chem. B, 2008, 112, 7120-7122.
15. Chen, Z. G.; Ding, W. F.; Ren, F. L.; Liu, J. B.; Liang, Y. Z. A simple and sensitive assay of nucleic acids based on the enhanced resonance light scattering of zwitterionics. Anal. Chim. Acta, 2005, 550, 204-209.
16. Chen, Z. G.; Liu, G. L.; Chen, M. H.; Peng, Y. R.; Wu, M. Y. Determination of nanograms of proteins based on decreased resonance light scattering of zwitterionic gemini surfactant. Anal. Biochem., 2009, 384, 337-342.
17. Chen, Z. G.; Liu, J. B.; Liang, Y. Z.; Ren, F. L. Use of sodium lauroyl sarcosinate in a high-sensitivity protein assay by resonance light scattering technique. J. Biomol. Screen., 2006, 11, 400-406.
18. Chen, Z. G.; Liu, J. B.; Han, Y. L.; Zhu L. A novel histidine assay using tetraphenylporphyrin manganese (III) chloride as a molecular recognition probe by resonance light scattering technique. Anal. Chim. Acta, 2006, 570, 109-115.
19. 2+-sodium dodecyl benzene sulfonate system and its analytical application. Anal. Chim. Acta, 2009, 632, 115-121.
20. Chen, Z. G.; Zhang T. Y.; Chen, X. M.; Han, Y. L.; Zhu, L. Interactions of norfloxacin with DNA and determination of DNA at nanogram levels based on the measurement of enhanced resonance light scattering. Microchim. Acta, 2007, 157, 107-112.
21. Ventrella, A.; Catucci, L.; Mascolo, G.; Corcelli, A.; Agostiano, A. Isolation and characterization of lipids strictly associated to PSII complexes: Focus on cardiolipin structural and functional role. BBA-Biomembranes, 2007, 1768, 1620-1627.
22. Cai, C. Q.; Chen, X. M.; Gong, H. Interaction of anticancer drug methotrexate with nucleic acids anslyzed by multi-spectroscopic method. Spectrochim. Acta A, 2009, 72, 46-49.
23. Collings, P. J.; Gibbs, E. J.; Starr, T. E.; Vafek, O.; Yee, C; Pomerance, L. A.; Pasternack, R. F. Resonance light scattering and its application in determining the size, shape, and aggregation number for supramolecular assemblies of chromophores. J. Phys. Chem. B, 1999, 103, 8474-8481.
24. Myers, C. E.; Minnaugh, E. G.; Yeh, G. C.; Sinha, B. K. Biochemical mechanisms of tumor cell kill by the anthracyclines. In: Lown, J. W., Ed.; Anthracycline and anthracenedione-based anticancer agents; Elsevier Science B. V: Amsterdam, 1988.
25. rd ed., Cold Spring Harbor Laboratory Press: New York, 2001.
26. Badirenaath Konkimalla, V.; Efferth T. Anti-cancer natural product library from traditional chinese medicine. Comb. Chem. High T. Scr., 2008, 11 (1), 7-15.
27. Nguyen, H. N.; Sevin, B.; Averette, H.; Perras, J.; Untch, M.; Ramos, R.; Donato, D.; Penalver, M. Comparative evaluation of pirarubicin and adriamycin in gynecologic cancer cell lines. Gynecol. Oncol, 1992, 45, 164-173.
28. Chugun, A.; Uchide, T.; Fujimori, Y.; Temma, K.; Hara, Y.; Sasaki, T.; Akera, T. Anti-muscarinic actions of mitoxantrone in isolated heart muscles of guinea pigs. Eur. J. Pharmacol, 2000, 407, 183-189.
29. Cutts, S. M.; Nudelman, A.; Rephaeli, A.; Phillips, D. R. The power and potential of doxorubicin-DNA adducts. Iubmb Life, 2005, 57, 73-81.
30. Riahi, S.; Ganjali, M. R.; Dinarvand, R.; Karamdoust, S.; Bagherzadeh, K.; Norouzi, P. A theoretical study on interactions between mitoxantrone as an anticancer drug and DNA: application in drug design. Chem. Biol. Drug Des., 2008, 71, 474-482.
31. Cummings, J.; Bartoszek, A.; Smyth, J. F. Determination of covalent binding to intact DNA, RNA, and oligonucleotides by intercalating anticancer drugs using high-performance liquid chromatography. Studies with doxorubicin and NADPH cytochrome P-450 reductase. Anal. Biochem., 1991, 194, 146-155.
32. Chien, M. J.; Groliman, A. P.; Horwitz, S. B. Bleomacin-DNA interactions: fluorescence and proton magnetic resonance studies. Biochemistry, 1977, 16, 3641-3677.
33. Su, H. B.; Williams, P.; Thompson, M. Platinum anticancer drug binding to DNA detected by thickness-shear-mode acoustic wave sensor. Anal. Chem., 1995, 67, 1010-1013.
34. Huang, C. Z.; Li, Y. F. Resonance light scattering technique used for biochemical and pharmaceutical analysis. Anal. Chim. Acta, 2003, 500, 105-117.
35. Borissevitch, I. E.; Tominaga, T. T.; Imasato, H.; Tabak, M. Resonance light scattering study of aggregation of two water soluble porphyrins due to their interaction with bovine serum albumin. Anal. Chim. Acta, 1997, 343, 281-286.
36. Li, Y.; Dong, L. J.; Wang, W. P.; Hu, Z. D.; Chen, X. G. Flow injection analysis-Rayleigh light scattering detection for online determination of protein in human serum sample. Anal. Biochem., 2006, 354, 64-69.
37. Vidal, E.; Palomeque, M. E.; Fernández Band, B. S. Flow injection analysis: Rayleigh light scattering technique for total protein determination. Anal. Bioanal. Chem., 2003, 376 (1), 38-41.
38. Xu, D. P.; Liu, S. P.; Liu, Z. F.; Hu, X. L. Determination of verapamil hydrochloride with 12-tungstophosphoric acid by resonance Rayleigh scattering method coupled to flow injection system. Anal. Chim. Acta, 2007, 588, 10-15.